Revvity (RVTY) EBT Growth (1y) (2010 - 2026)
Revvity (RVTY) EBT Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,149.49 Bn | 29,149.03 Bn | 1.11 Bn | -161.54% |
| 2 | Thermo Fisher Scientific | 174.37 Bn | 171.12 Bn | 7.74 Bn | 7.04% |
| 3 | Danaher | 127.33 Bn | 121.64 Bn | 3.59 Bn | 9.39% |
| 4 | Idexx Laboratories | 44.68 Bn | 44.48 Bn | 722.74 Mn | 14.63% |
| 5 | Agilent Technologies | 36.54 Bn | 34.74 Bn | 990.00 Mn | 56.92% |
| 6 | Iqvia Holdings | 30.51 Bn | 28.53 Bn | 1.36 Bn | 1.55% |
| 7 | Natera | 30.00 Bn | 28.90 Bn | 696.04 Mn | -27.03% |
| 8 | Illumina | 24.61 Bn | 23.45 Bn | 721.00 Mn | -13.74% |
| 9 | Mettler Toledo International | 22.91 Bn | 22.85 Bn | 555.82 Mn | 3.82% |
| 10 | Revvity | 11.15 Bn | 10.29 Bn | 387.66 Mn | -4.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | -4.56% |
| Dec 28, 2025 | -3.17% |
| Sep 28, 2025 | -44.51% |
| Jun 29, 2025 | -20.78% |
| Mar 30, 2025 | 51.62% |
| Sep 29, 2024 | 98.32% |
| Jun 30, 2024 | 21.11% |
| Mar 31, 2024 | 17.35% |
| Oct 1, 2023 | -38.40% |
| Jul 2, 2023 | -65.32% |
| Apr 2, 2023 | -86.91% |
| Jan 1, 2023 | -53.81% |
| Oct 2, 2022 | -39.16% |
| Jul 3, 2022 | -31.52% |
| Apr 3, 2022 | -51.90% |
| Jan 2, 2022 | -36.65% |
| Oct 3, 2021 | -42.24% |
| Jul 4, 2021 | 82.82% |
| Apr 4, 2021 | 1,247.80% |
| Jan 3, 2021 | 624.53% |